FDA Looks to China to Address Cancer Drug Shortage

The Agency assured the public that it will continue its efforts to help the industry meet the needs of patients affected by oncology drug shortages.

Getty Images
Getty Images

According to a recent NBC News article, the FDA is partnering with a Chinese drugmaker, Qilu Pharmaceutical, to import the chemotherapy drug cisplatin in an effort to address the ongoing shortage of the drug in the United States. Cisplatin has been in short supply since February, and the FDA's collaboration with Qilu Pharmaceutical aims to ramp up the drug's availability by importing it from China. The medication will be distributed in the US through Canada-based drugmaker Apotex. The FDA is also exploring the possibility of importing carboplatin, another chemotherapy drug facing shortages.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report